Cargando…

P.508 COVID-19 impact on entry symptom severity in schizophrenia clinical trials – preliminary data

Detalles Bibliográficos
Autores principales:	Kott, A., Daniel, D.G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670888/ http://dx.doi.org/10.1016/j.euroneuro.2020.09.372

Ejemplares similares

S246. THE EFFECT OF INCORRECT SCALE ADMINISTRATION ON DATA QUALITY IN SCHIZOPHRENIA CLINICAL TRIALS
por: Kott, Alan, et al.
Publicado: (2020)

The Impact of Aberrant Data Variability on Drug–Placebo Separation and Drug/Placebo Response in an Acute Schizophrenia Clinical Trial
por: Kott, Alan, et al.
Publicado: (2021)

T47. IS THERE A DIURNAL VARIATION IN PSYCHIATRIC SYMPTOMS IN SCHIZOPHRENIA?
por: Daniel, David, et al.
Publicado: (2018)

Answer to the question page 508
Publicado: (2012)

A microprocessor data-capture and data-base package for the IL508 analyser
por: Clark, Barry, et al.
Publicado: (1984)

Effect of thrombin peptide 508 (TP508) on bone healing during distraction osteogenesis in rabbit tibia
por: Amir, Lisa R., et al.
Publicado: (2007)

P079 Real-life data on the efficacy and safety of tezacaftor/ivacaftor in people living with cystic fibrosis homozygous for F508del and heterozygous for F508del and a residual function mutation
por: Vincken, S., et al.
Publicado: (2022)

Non‐pulmonary CFTR‐related symptom improvement with ivacaftor in p.Phe508del/p.Arg117His (7T) cystic fibrosis
por: Kuek, Stephanie L., et al.
Publicado: (2022)

T100. NICOTINE USE IMPACTS NEGATIVE SYMPTOMS SEVERITY IN SCHIZOPHRENIA
por: Oliveira, Hianna, et al.
Publicado: (2018)

P.F508del editing in cells from cystic fibrosis patients
por: Smirnikhina, Svetlana A., et al.
Publicado: (2020)

Attitudes toward COVID-19 pandemic measures and clinical symptom severity in schizophrenia patients: a preliminary cross-sectional study
por: Onur, Durmaz, et al.
Publicado: (2023)

Accessibility handbook: making 508 websites for everyone
por: Cunningham, Katie
Publicado: (2012)

I4 Hotspot: runs 505 and 508
por: Risselada, Thys
Publicado: (1974)

Production of CFTR-ΔF508 Rabbits
por: Yang, Dongshan, et al.
Publicado: (2021)

Statistical validation of the criteria for symptom remission in schizophrenia: Preliminary findings
por: Opler, Mark GA, et al.
Publicado: (2007)

SUN-508 Dissociation of Clinical Course of Coexisting Autoimmune Hepatitis and Graves Disease
por: Patel, Aesha, et al.
Publicado: (2020)

Clinical Features of COVID-19 Patients in Jordan: A Study of 508 Patients
por: Al-Balas, Mahmoud, et al.
Publicado: (2021)

Impact of MIF Gene Promoter Polymorphism on F508del Cystic Fibrosis Patients
por: Melotti, Paola, et al.
Publicado: (2014)

Case report: Three adult brothers with cystic fibrosis (delF508-delF508) maintain unusually preserved clinical profile in the absence of standard CF care
por: Bishop, Clark T.
Publicado: (2021)

Decoding F508del Misfolding in Cystic Fibrosis
por: Wang, Xiaodong Robert, et al.
Publicado: (2014)

Recovery of ΔF508-CFTR Function by Citrate
por: Borkenhagen, Beatrice, et al.
Publicado: (2022)

FRI508 A Case Of Durvalumab Induced Hypothyroidism
por: Cecilio La Riva, Estefania Del Valle, et al.
Publicado: (2023)

A novel way to quantify schizophrenia symptoms in clinical trials
por: Medvedev, Oleg N., et al.
Publicado: (2020)

Defective Fluid Secretion from Submucosal Glands of Nasal Turbinates from CFTR(-/-) and CFTR(ΔF508/ΔF508) Pigs
por: Cho, Hyung-Ju, et al.
Publicado: (2011)

Influence of CFH gene on symptom severity of schizophrenia
por: Zhang, Chen, et al.
Publicado: (2017)

SAT-508 A Case Report Of Severe Hypercalcaemia Due To Iatrogenic (oral Supplements), Aki And Immobility
por: Khan, Inamullah, et al.
Publicado: (2019)

First Insights into the Genome of the Moderately Thermophilic Bacterium Clostridium tepidiprofundi SG 508(T)
por: Poehlein, Anja, et al.
Publicado: (2016)

Role of microRNA508-3p in melanogenesis by targeting microphthalmia transcription factor in melanocytes of alpaca
por: Zhang, J., et al.
Publicado: (2016)

hsa-miR-508-5p as a New Potential Player in Intervertebral Disc Degeneration
por: Gholipour, Akram, et al.
Publicado: (2022)

An evaluation of the IL 508 eight-channel blood-chemistry analyser
por: Logan, R. W., et al.
Publicado: (1982)

Benzbromarone Stabilizes ΔF508 CFTR at the Cell Surface
por: Loo, Tip W., et al.
Publicado: (2011)

In vivo model for modulators of CFTR(ΔF508) misfolding
Publicado: (2012)

Correctors modify the bicarbonate permeability of F508del-CFTR
por: Fiore, Michele, et al.
Publicado: (2020)

The Impact of Electroconvulsive Therapy on Negative Symptoms in Schizophrenia and Their Association with Clinical Outcomes
por: Tan, Xiaowei, et al.
Publicado: (2022)

Altered gut microbiota associated with symptom severity in schizophrenia
por: Li, Shijia, et al.
Publicado: (2020)

Clinical Global Impression of Cariprazine in Negative Symptom Schizophrenia Patients: Comparison of clinical trial data vs. real-world evidence
por: Rancans, E., et al.
Publicado: (2023)

Motor-related oscillatory activity in schizophrenia according to phase of illness and clinical symptom severity
por: Gascoyne, Lauren E., et al.
Publicado: (2020)

The Relationship between 10 Years Risk of Cardiovascular Disease and Schizophrenia Symptoms: Preliminary Results
por: Kilicaslan, Esin Evren, et al.
Publicado: (2019)

miR-508-3p suppresses the development of ovarian carcinoma by targeting CCNA2 and MMP7
por: Guo, Fei, et al.
Publicado: (2020)

Phosphorylation at tyrosine 317 and 508 are crucial for PIK3CA/p110α to promote CRC tumorigenesis
por: Wang, Ting, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c26nr34ijd7bnt87lsaj8cudkq